In last trading session, Prothena Corporation plc (NASDAQ:PRTA) saw 0.44 million shares changing hands with its beta currently measuring 0.40. Company’s recent per share price level of $34.06 trading at -$0.43 or -1.25% at ring of the bell on the day assigns it a market valuation of $1.83B. That closing price of PRTA’s stock is at a discount of -133.85% from its 52-week high price of $79.65 and is indicating a premium of 16.29% from its 52-week low price of $28.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.67 million shares which gives us an average trading volume of 640.63K if we extend that period to 3-months.

For Prothena Corporation plc (PRTA), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 1.36. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 9 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$1.22 in the current quarter.

Prothena Corporation plc (NASDAQ:PRTA) trade information

Upright in the red during last session for losing -1.25%, in the last five days PRTA remained trading in the green while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $34.06 price level, adding 10.58% to its value on the day. Prothena Corporation plc’s shares saw a change of -43.47% in year-to-date performance and have moved 2.22% in past 5-day. Prothena Corporation plc (NASDAQ:PRTA) showed a performance of -23.63% in past 30-days. Number of shares sold short was 6.5 million shares which calculate 6.96 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $83.45 to the stock, which implies a rise of 59.19% to its current value. Analysts have been projecting $43.00 as a low price target for the stock while placing it at a high target of $129.00. It follows that stock’s current price would drop -278.74% in reaching the projected high whereas dropping to the targeted low would mean a loss of -26.25% for stock’s current value.

Prothena Corporation plc (PRTA) estimates and forecasts

Statistics highlight that Prothena Corporation plc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -53.86% of value to its shares in past 6 months, showing an annual growth rate of -12.15% while that of industry is 14.80. Apart from that, the company came lowering its revenue forecast for fiscal year 2023. The company is estimating its revenue growth to decrease by -1,116.70% in the current quarter and calculating -48.30% decrease in the next quarter. This year revenue growth is estimated to rise 72.50% from the last financial year’s standing.

9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $1.91 million for the same. Company posted $49.92 million and $2.17 million of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 9.51% during past 5 years. In 2023, company’s earnings growth rate is likely to be around -16.22% while estimates for its earnings growth in next 5 years are of -0.60%.

PRTA Dividends

Prothena Corporation plc is more likely to be releasing its next quarterly report between February 12 and February 16 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Prothena Corporation plc (NASDAQ:PRTA)’s Major holders

Insiders are in possession of 4.71% of company’s total shares while institution are holding 99.21 percent of that, with stock having share float percentage of 104.11%. Investors also watch the number of corporate investors in a company very closely, which is 99.21% institutions for Prothena Corporation plc that are currently holding shares of the company. EcoR1 Capital, LLC is the top institutional holder at PRTA for having 11.58 million shares of worth $394.56 million. And as of Sep 29, 2023, it was holding 21.59% of the company’s outstanding shares.

The second largest institutional holder is FMR, LLC, which was holding about 8.03 million shares on Sep 29, 2023. The number of shares represents firm’s hold over 14.96% of outstanding shares, having a total worth of $273.51 million.

On the other hand, Fidelity Growth Company Fund and Price (T.Rowe) New Horizons Fund are the top two Mutual Funds which own company’s shares. As of Aug 30, 2023, the former fund manager was holding 2.14 million shares of worth $72.87 million or 3.99% of the total outstanding shares. The later fund manager was in possession of 1.66 million shares on Jun 29, 2023, making its stake of worth around $56.41 million in the company or a holder of 3.09% of company’s stock.